iBio Inc.


Recent Releases, Events & Media Assets


Latest News

iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint development of products and manufacturing facilities for the Chinese biopharmaceutical market,

Read Press Release

Latest Presentation

Upcoming Event

Dr. Carol Fengali-Bostwick presents at the Scleroderma Foundation – Courtesy of the Scleroderma Foundation, Inc.

Learn More